Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 15, 2024, titled "Sun Pharma to announce second quarter results on October 28, 2024".
Press Release Oct 15 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for commercializing the specialty product FIBROMUN
- Press Release Oct 01 2024
- Press Release Sep 26 2024
- Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
- Press Release Sep 06 2024
Later from Sun Pharmaceutical Industries
- Press Release Oct 25 2024
- Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference
- Press Release Feb 04 2025
- Press Release Feb 17 2025
- Sun Pharmaceutical Industries Limited Press Release Apr 07 2025
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries